2025 ISAKOS Congress in Munich, Germany

2025 ISAKOS Biennial Congress ePoster

 

Effect Of Preoperative Opioid Consumption On Short-Term Outcomes Of Hip Arthroscopy

Roger Quesada Jimenez, MD, Des Plaines, Illinois UNITED STATES
Drashti Sikligar, MEng, Des Plaines, IL UNITED STATES
Andrew R. Schab, BS, Des Plaines, Illinois UNITED STATES
Ady Haim Kahana Rojkind, MD, Des Plaines, IL UNITED STATES
Benjamin G. Domb, MD, Des Plaines, Illinois UNITED STATES

American Hip Institute Research Foundation, Des Plaines, Illinois, UNITED STATES

FDA Status Cleared

Summary

Hip arthroscopy for the treatment of femoroacetabular impingement and labral tears in patients with preoperative daily opioid-based pain control medications resulted in significant short-term improvements in patient-reported outcomes, but these patients achieved lower patient satisfaction compared to a benchmark control group.

ePosters will be available shortly before Congress

Abstract

Purpose

Report short-term outcomes of self-reported preoperative opioid-based pain control management in patients who underwent hip arthroscopy for femoroacetabular impingement (FAI) and labral tears. A secondary analysis compared these results to a benchmark control group of patients without preoperative opioid consumption.

Methods

Data were prospectively collected and retrospectively analyzed for patients who underwent primary hip arthroscopy for FAI and labral tears between 2009 and 2021. Patients were included if they reported preoperative daily opioid-based pain control medications (PO) within one year of surgery and had completed pre- and postoperative patient-reported outcomes (PROs) with minimum 2 year follow-up. Clinically relevant thresholds, revision surgery, and conversion to arthroplasty rates were included in the analysis. Patients were propensity matched to a benchmark control group of patients without preoperative opioid consumption in a 1:1 ratio based on sex, age at surgery, body mass index, Acetabular Outerbridge Grade, labral and capsular treatment.

Results

472 patients were included in the study. 236 patients in the PO cohort successfully matched to 236 control cases of non-opioid consumption patients. The PO group displayed significant improvements across all PROs and high patient satisfaction. However, compared to the benchmark control group, PO patients started with lower preoperative scores for mHHS, NAHS, and VAS. Similar magnitudes of improvement were observed for mHHS, NAHS, HOS-SSS, and VAS, reaching similar postoperative scores. Despite these improvements, PO patients reported significantly lower patient satisfaction at the latest follow-up. There were no differences in rates of achieving MCID and PASS, experiencing complications or undergoing secondary surgeries.

Conclusion

Hip arthroscopy for the treatment of FAI and labral tears in patients with preoperative daily opioid-based pain control medications resulted in significant short-term improvements in PROs. However, compared to a benchmark control group, these patients achieved lower patient satisfaction, which should be considered when managing patient expectations.